Gene Therapy
Collection
Collection
- ISSN: 09697128
Published by Macmillan, London
-
The expression of bacterial nitroreductase in eukaryotic cells results in their killing by the prodrug CB1954. Article
Gene Therapy, 93-100.D.D. Drabek (Dubravka), J.A. Guy (Jacqueline) and F.G. Grosveld (Frank)
January 1997
-
Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants Article
Gene Therapy, 6(6), 1139-1146.E. Braakman (Eric), R. Vogels, A.C.M. Martens (Anton), J. Vermeulen, M. Bron (M.), P.M. Hoogerbrugge (Peter), D. Valerio (Dinko) and A. Hagenbeek (Anton)
June 1999 -
Expression of Coxsackie adenovirus receptor and alpha(v)-integrin does not correlate with aconovector targeting in vivo indicating anatomical vector barriers Article
Gene Therapy, 6(9), 1520-1535.H. Fechner, A. Haack (A.), H. Wang (H.), X. Wang (X.), K. Eizema (Karin), M. Pauschinger (M.), R.G. Schoemaker (Regien), R. van Veghel (Richard), A.B. Houtsmuller (Adriaan), H.P. Schultheiss (Heinz-Peter), et al. J.M.J. Lamers (Jos) and W.C. Poller
September 1999 -
A multi-domain protein for beta1 integrin-targeted DNA delivery. Article
Gene Therapy, 7(17), 1505-1515.E. Fortunati (Elisabetta), E.M.E. Ehlert (Ehrich), N.D. van Loo, C. Wyman (Claire), J.A. Eble, F.G. Grosveld (Frank) and B.J. Scholte (Bob)
January 2000
-
A phage display selected Fab fragment with MHC class i-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes Article
Gene Therapy, 8(21), 1601-1608.R.A. Willemsen (Ralph), J.E.M.A. Debets (Reno), E. Hart (E.), L.C.A. Hoogenboom, R.L.H. Bolhuis (Reinder) and P. Chames
December 2001 -
LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors Article
Gene Therapy, 9(5), 327-336.Chow, C.-M. (C. M.), A. Athanassiadou (Aglaia), S. Raguz (Selina), Psiouri, L. (L.), Harland, L. (L.), Malik, M. (M.), Aitken, M.A. (M. A.), F.G. Grosveld (Frank) and M. Antoniou (Michael)
March 2002 -
Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious Article
Gene Therapy, 10(21), 1800-1806.T. Ebeling (Tapani), E.R. Simonetti (E.), H.P.E. Borst (Eric), A. Blok (A.), A.M. Schelen (Anita), E. Braakman (Eric), J. Ederveen (J.) and A. Hagenbeek (Anton)
October 2003 -
Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR αβ gene transfer requires CD8α Article
Gene Therapy, 12(2), 140-146.R.A. Willemsen (Ralph), C. Ronteltap, M. Heuveling (Mirjam), J.E.M.A. Debets (Reno) and R.L.H. Bolhuis (Reinder)
January 2005